Critical review of the CLOSURE-AF trial provides new insights and calls for a careful re-evaluation of its clinical findings.
Absolute Event Rate: 0% vs 0%
Philippe Garot, MD, PhD, Jens Erik Nielsen-Kudsk, MD, PhD, Ole De Backer, MD, PhD; Decoding the CLOSURE-AF Trial: New Insights and a Call for Critical Revi
Garot et al. (Thu,) reported a other. Critical review of the CLOSURE-AF trial provides new insights and calls for a careful re-evaluation of its clinical findings.